William Desmarais - 15 Jul 2021 Form 3 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Business Officer
Signature
/s/ William Desmarais
Issuer symbol
TCRX
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
3
Filing time
15 Jul 2021, 18:24:13 UTC
Next filing
31 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCRX Employee Stock Option (right to buy) 15 Jul 2021 Voting Common Stock 119,688 $13.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest over 4 years of service following March 22, 2021, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.